IENSX | VENAX | IENSX / VENAX | |
Total Expense Ratio | 0.85 | 0.09 | 944% |
Annual Report Gross Expense Ratio | 0.85 | 0.09 | 944% |
Fund Existence | 8 years | 21 years | - |
Gain YTD | 8.759 | 3.549 | 247% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 100000 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 425M | 9B | 5% |
Annual Yield % from dividends | 3.64 | 3.07 | 118% |
Returns for 1 year | 10.41 | 3.38 | 308% |
Returns for 3 years | 27.27 | 12.57 | 217% |
Returns for 5 years | 218.13 | 169.13 | 129% |
Returns for 10 years | N/A | 38.08 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBRN | 25.90 | 0.47 | +1.86% |
iShares Neuroscience and Healthcare ETF | |||
BINV | 37.61 | 0.39 | +1.05% |
Brandes International ETF | |||
RSF | 14.80 | 0.02 | +0.14% |
RiverNorth Capital and Income Fund | |||
PTNQ | 74.26 | -0.01 | -0.02% |
Pacer Trendpilot™ 100 ETF | |||
JANM | 32.22 | -0.01 | -0.04% |
FT Vest U.S. Eq Max Buffr ETF - Jan |